Just Another One of Those Quarters for CHE
Bottom Line:
Large Q3 miss (water the only bright spot) with 2020E EBITDA seemingly ~$275M
and some 2021 guidance commentary implying to us 2021 EBITDA ~$300M, implying
a 75-80% 2021E payout ratio. There's sizable upside if CHE can recover earnings (to
the high end of "normalized" ~$300-350M earnings), and right the ship, but finding
conviction amid high payout ratios is difficult (it may have to start with sharp caustic
recovery). Our target price is ~6x 2021E EV/EBITDA
Adj. Q3 EBITDA of $65M (down ~28% y/y, ~14% q/q) missed $75M consensus
(BMO: $76M estimate). Distributable cash after maintenance capex was $12.1M ($0.13/
unit), a ~115% payout.